INTRODUCTION
In most cases, tumors grow in their primary hosts or syngeneic recipients without beeing hampered by the immune system, even if the tumor cells express immunogenic neoantigens. The lack of apparent immunogenicity of tumors in situ might be due to special properties of the tumor cells, for example lack of costimulatory molecules, downregulation of MHC molecules, or production of immunosuppressive factors (Browning and Bodmer, 1992; Chen et al., 1992; Sulizeanu, 1993) , or due to intrinsic tolerance mechanisms of the immune system (Mengersen et al., 1975;  Naor, 1979; North, 1985) . Under (Cihak et al., 1981) , which leads to the activation of tumor-specific CD8 Tc cells. Specific CD8 Tc cells against the tumor can also be induced in vitro, in a primary syngeneic mixed lymphocyte tumor cell culture (MLTC) (Haubeck and K61sch, 1982) . However, the growth of ADJ-PC-5 tumor cells in syngeneic BALB/c mice is accompanied by the induction of a subset of CD8 regulatory T cells, which are characterized by their ability to suppress the induction of tumor-specific CD8 Tc cells in a primary MLTC in vitro K61sch, 1982, 1986) . These suppressive T cells are induced during early stages of tumorigenesis, when the tumor burden is small, and possibly hold down a protective cytotoxic T-cell (Tc) response against the tumor, even when the tumor mass reaches an immunogenic level. Recent data indicate that the T-cell-mediated suppressive effect in vitro involves IFN-T as a suppressor factor, but does not depend on IL-2 consumption (Pauels et al., 1996) .
The finding that IFN-T is a suppressive factor for Tc induction in vitro prompted us to study phenotypes and activation modalities of ADJ-PC-5-specific Tc cells in more detail.
RESULTS
Simulation of ADJ-PC-5 Tumor Growth in the Peritoneal Cavity is Accompanied by the Induction of IFN-y-Producing Suppressive CD8
T Cells
In previous studies, an in vitro protocol for the induction of ADJ-PC-5-specific Tc cells was developed, which is based on a primary syngeneic MLTC (Haubeck and K61sch, 1982) . As shown in Figure (a K61sch, 1982, 1986 (Pauels et al., 1996) .
DISCUSSION
Although the BALB/c plasmacytoma ADJ-PC-5 is highly immunogenic, tumor growth in syngeneic (Sad et al., 1995) .
Nevertheless, at least two of five ADJ-PC-5-specific CD8 T-cell lines, which were derived from a primary MLTC by repeated restimulation with X-irradiated tumor cells, are IL-4-producing Tc2 cells. Whereas in other experimental systems, the addition of high amounts of IL-4 and blocking antibodies against IFN-3/ is a prerequisite for the generation of antigenspecific Tc2 lines (Sad et al., 1995) 
IFN-T.
In this context, the Tcl cells behave similar to the previously described CD8 suppressive T cells from tumor-tolerant mice (Pauels et al., 1996) . However, these suppressive CD8 T cells did never show any significant cytotoxicity against ADJ-PC-5 cells, whereas the Tcl lines are potent tumor-specific Tc cells. It is presently not clear if the suppressive T cells in tumor-tolerant mice are Tc 1 cells that in situ occur at frequencies too low to cause any substantial cytotoxicity or if they are incompletely activated Tc cells, which produce suppressive cytokines but are not sufficiently activated for cytotoxicity.
IL-10 has been described as a cytotoxic T-cell differentiation factor (Chang and Zlotnik, 1991) , as well as an inhibitor of CD8 cytotoxic T-cell responses in primary allogenic MLC cultures (Bejarano et al., 1992). Thus, the effects of IL-10 on CD8 T cells seem to depend on the kind of CD8 T-cell response studied. In our experimental system, tumorderived IL-10 is an essential differentiation factor for the induction of CD8 ADJ-PC-5-specific Tc cells, since blocking of IL-10 in MLTC cultures by monoclonal antibodies can completely abrogate the tumor-specific Tc response. Production of IL-10 is a general property of malignancies of the B-lymphocyte lineage (Bost et al., 1995) . It has previously been shown for CD4 T cells that IL-10, which is produced by Th2 cells, is a potent inhibitor of Thl functions (Fiorentino et al., 1989) , whereas Thl cells are able to suppress Th2 cells via IFN-T (Gajewski and Fitch, 1988) . It is also known that Thl functions are drastically decreased in mice bearing IL-10-producing plasma-cell tumors (Ruzek and Mathur, 1995) . Therefore, it is likely that production of IL-10 by ADJ-PC-5 cells strongly influences the CD8 Tc-cell response against the tumor. In this context, high cell numbers of ADJ-PC-5 cells, which are present in a MLTC produce sufficiently high amounts of IL-10 to dictate a Tc2-dominated response against the tumor in vitro. On the other hand, low numbers of tumor cells, which are present during early stages of tumorigenesis in vivo, could result in a Tcl-dominated response due to a lack of substantial amounts of IL-10. The same seems to be true for mice that were weekly immunized with high numbers or X-irradiated ADJ-PC-5 tumor cells.
In this case, the IL-10 might be rapidly cleared from 
MATERIALS AND METHODS

Mice and Tumors
Female BALB/c mice were aged 8 to 12 weeks at the beginning of each experiment. The animals were either purchased from Charles River (Sulzfeld, Germany) or bred at our own animal facility. The nonsecreting variant of the BALB/c plasmacytoma ADJ-PC-5 (ADJ-PC-5-NS) (Blatt and Ha'fmovich, 1977) , originally obtained from J. Ha'fmovich (Weizmann Institute, Rehovot, Israel) was used as a model tumor. The BALB/c fibrosarcoma Meth A (Old et al., 1962) , the DBA/2 plasmacytoma ULMC (Bosslet et al., 1979) , and the BALB/c B-cell lymphoma A20 (Kim et al., 1979) were used as control tumors in some experiments.
Generation of Tumor-Induced Suppressive T Cells by Tumor Growth Simulation
The in vivo induction of suppressive T cells by tumor growth simulation has been previously described (Haubeck and K61sch, 1982 (Haubeck and K61sch, 1982) . Briefly, 2 10 7 BALB/c spleen cells were cultured with 10 6 60-Gy X-irradiated ADJ-PC-5 cells in 10 ml of MLC medium for 6 days. Thereafter, cells were harvested and tested in a 6-hr 51Cr-release assay for specific cytotoxicity (Haubeck and K61sch, 1982 were determined by means of a sandwich ELISA using 2A5.7 (Sander et al., 1993) , and biotinylated XT1 monoclonal anti-bodies for IL-10, R4-6A2 (Spitalny and Havell, 1984) , and biotinylated XMG 1.2 for IFN-y, 11B 11 (Ohara and Paul, 1985) , and biotinylated BVD6-24G2 for IL-4. All biotinylated monoclonal antibodies were purchased from Pharmingen (San Diego).
In Vitro Assay for T-Cell-Mediated Suppression
To test their suppressive capacity, nonadherent PEC from naive and tumor-treated mice, or 30-Gy Xirradiated ADJ-PC-5-specific Tc cells were added to an ADJ-PC-5-specific MLTC (as described earlier) at day 0 of culture. After 6 days, specific cytotoxic activity against ADJ-PC-5 cells was measured in a 6-hr 51Cr-release assay and compared with the cytotoxicity from cultures without added T cells. For some experiments, IFN-y-specific monoclonal antibodies were added to the cultures at various concentrations.
Flow Cytometric Analysis
For flow cytometric analysis of surface markers on tumor-specific T cells, cells were harvested and washed with BSS. For two-parameter analysis of V/3 expression on CD8 ADJ-PC-5-specific Tc lines, cells were incubated with FITC-coupled, V/3-specific, and PE-coupled CD8-specific monoclonal antibodies (Pharmingen, San Diego). All washing and incubation steps were performed with ice-cold MLC medium containing 0.1% NAN3. Labeled cells were analyzed using a FACScan flow cytometer (Becton-Dickinson, Heidelberg). Prior to flow cytometric analysis, samples were incubated with 10/zg/ml propidiumiodide to discriminate dead cells from living cells.
Detection of Intracellular Cytokines
Staining of intracellular cytokines was performed according to the saponin/monensin method, as described elsewhere (Jung et al., 1993 
